Continuum Advisory’s Corteva CTVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-957
Closed -$60.2K 654
2025
Q1
$60.2K Sell
957
-55
-5% -$3.4K 0.01% 625
2024
Q4
$57.6K Sell
1,012
-2
-0.2% -$118 0.01% 627
2024
Q3
$58.2K Buy
1,014
+138
+16% +$7.54K 0.01% 626
2024
Q2
$47.2K Hold
876
0.01% 617
2024
Q1
$50.6K Buy
+876
New +$45.2K 0.01% 597
2023
Q4
Sell
-18,659
Closed -$955K 457
2023
Q3
$955K Buy
18,659
+7,684
+70% +$407K 0.15% 170
2023
Q2
$629K Buy
10,975
+1,330
+14% +$77.6K 0.1% 243
2023
Q1
$582K Buy
9,645
+2,914
+43% +$178K 0.1% 241
2022
Q4
$396K Buy
6,731
+1,555
+30% +$98.4K 0.07% 302
2022
Q3
$296K Buy
+5,176
New +$302K 0.05% 324

Other funds holding CTVA

Continuum Advisory's CTVA Position: Q2 2025 in Review

Continuum Advisory sold out of Corteva (CTVA) in Q2 2025, closing a stake of 957 shares — an estimated $60.2K sold.

Continuum Advisory first reported a position in CTVA in Q3 2022 and held it in 10 quarters. The position peaked at $955K in Q3 2023. 1,400 funds tracked by Wall St. Rank hold CTVA as of Q2 2025.

  • Continuum Advisory reported no remaining Corteva position as of Q2 2025 after selling out during the quarter.
  • Continuum Advisory sold 957 Corteva shares in Q2 2025, an estimated $60.2K.
  • Continuum Advisory first reported a position in Corteva in Q3 2022 and held it in 10 quarters.
  • Continuum Advisory's Corteva position peaked at $955K in Q3 2023.
  • 1,400 funds tracked by Wall St. Rank held Corteva as of Q2 2025.

Based on Continuum Advisory's 13F filing for Q2 2025, filed 13 Aug 2025.